Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TRICARIX

Financiado

Cerrado

Minimally invasive transcatheter system for tricuspid heart valve replacement

TRiCares is a medical technology company with the mission to develop and commercialize innovative minimally invasive (transcatheter) solutions replacing high-risk open-heart surgeries for treatment of heart valve diseases. Heart v... ver más

30/11/2022

TRICARES GMBH

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

TRICARES GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-11-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 57% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

TRICARES GMBH

2.48M€ | Lider

FHIOS CONSULTORIA TECNOLOGIC...

631.74K€ | Participante

TRICARES SAS

2.13M€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Trillium A transcatheter functional valve replacement for tricuspid v... 6M€ Cerrado

TriSol System A heart valve prosthesis and delivery system intended to rep... 71K€ Cerrado

Trisol System A safe and effective replacement valve for treating severe T... 3M€ Cerrado

Duo Duo A minimally invasive device to treat all patients with... 4M€ Cerrado

CVTVT A Non Surgical Treatment to Restore Heart Valve Function 5M€ Cerrado

TRIFLO One Valve For Life The First Durable Non Thrombotic Heart V... 4M€ Cerrado

Duración del proyecto: 48 meses Fecha Inicio: 2018-11-15
Fecha Fin: 2022-11-30

Líder del proyecto

TRICARES GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto TRiCares is a medical technology company with the mission to develop and commercialize innovative minimally invasive (transcatheter) solutions replacing high-risk open-heart surgeries for treatment of heart valve diseases. Heart valve diseases are among the most serious cardiac complications affecting >12.7 million patients in Europe. Cardiac surgeons are urgently seeking for a low-risk minimally invasive solution to treat annually >300,000 patients with tricuspid heart valve disease, who are currently simply dying because of having no relevant therapeutic option. TRiCares has uniquely addressed technological challenges associated with tricuspid heart valve disease treatment- the company has developed the first-of-its-kind medical device for tricuspid heart valve replacement (TRICARIX) based on a proprietary dual-stent prosthesis platform. The product addresses a fast-growing transcatheter heart valve replacement/repair market, that is driven by the increasing demand to treat heart valve diseases in the aging population. As no such solution is available for tricuspid valve, introduction of the TRICARIX will create a novel market segment with estimated total market potential of €1 billion in Europe only. The company’s strategy has been built along the regulatory route to obtain CE-marking for the TRICARIX medical device in 2021. TRiCares is led by experienced entrepreneur and experts with successful track record of bringing medical devices to market, including the first European transcatheter aortic valve replacement system in 2012. TRiCares seeks SMEInstr funding to reach the critical First-In-Man study milestone (total costs-of the project €4.3 million) that will greatly facilitate follow-up capital investments to finance the final large-scale efficacy/safety clinical study. CE-marking will position the product/company for a licensing agreement with a global medical device company to ensure effective marketing and clinical implementation of the device.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores